reports
Reliance, Inc. Announces Upcoming Conference Participation
Reliance, Inc. Announces Upcoming Conference Participation SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Reliance, Inc. (NYSE: RS) announced today that its management team will participate in the following upcoming investor conferences: The BofA Securities 2024 Global Metals, Mining & Steel Conference on Tuesday, May 14, 2024 in Miami, Florida. Karla Lewis, President and Chief Executive Officer, and Arthur Ajemyan, Senior Vice President and Chief Financial Officer, are scheduled to present on Tuesday, May 14th at 5:30 p.m. ET and will participate in meetings with investors throug...
Chevron Corp: 1 director
A director at Chevron Corp sold 7,647 shares at 162.667USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Sensata Technologies Holding plc: 1 director
A director at Sensata Technologies Holding plc bought 268,310 shares at 39.642USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
SOPHiA GENETICS Reports First Quarter 2024 Results
SOPHiA GENETICS Reports First Quarter 2024 Results Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Revenue grew 13% year-over-year to $15.8 million; Constant currency revenue excluding COVID-related revenue grew 12% year-over-yearGross margins were 65.9% on a reported b...
Unitil Reports First Quarter Earnings
Unitil Reports First Quarter Earnings HAMPTON, N.H., May 07, 2024 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) () today announced Net Income of $27.2 million, or $1.69 in Earnings Per Share (EPS), for the quarter ended March 31, 2024, an increase of $3.1 million in Net Income, or $0.18 in EPS, compared to the same period in 2023. The Company’s Electric and Gas GAAP Gross Margins were $20.1 million and $50.2 million, respectively, for the first quarter of 2024. “We continued to deliver on our commitments to stakeholders with strong operational and financial performance in the first ...
Gray’s Operating Results for the First Quarter Driven by Continued Str...
Gray’s Operating Results for the First Quarter Driven by Continued Strong Demand and Execution; Gray Announces New $250 Million Debt Repurchase Authorization ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray,” “we,” “us” or “our”) (NYSE: GTN) today announced financial results for the first quarter ended March 31, 2024, reflecting our total revenue of $823 million and total operating expenses (before depreciation, amortization and loss on disposal of assets) of $632 million. Overall, we believe that our businesses have started 2024 in a strong position. The first quar...
TopBuild Reports First Quarter Results, Raises 2024 Outlook and Announ...
TopBuild Reports First Quarter Results, Raises 2024 Outlook and Announces $1B Share Repurchase Authorization First quarter sales grow 1.1% to $1.3 billion Gross margin expands 100 basis points to 30.3% Adjusted EBITDA margin expands 100 basis points to 19.8% DAYTONA BEACH, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD) a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada today reported results for the first quarter ended March 31, 2024. Robert Buck, President an...
Healthcare Realty Trust Reports Results for the First Quarter
Healthcare Realty Trust Reports Results for the First Quarter The Company is focused on its top priorities of capital allocation and operational momentum to accelerate FFO growth and improve dividend coverage. CAPITAL ALLOCATION MOMENTUM Announced a $383 million JV with KKR at a 6.6% cap rate with expected proceeds of $300 millionExpects additional proceeds of more than $300 million within 90 days from separate transactionsRepurchased 3.0 million shares totaling $41.7 million in April OPERATIONAL MOMENTUM Delivered multi-tenant absorption of 57,000 square feet, or 17 basis point...
Resolutions of the Annual General Meeting of Shareholders of AS Tallin...
Resolutions of the Annual General Meeting of Shareholders of AS Tallink Grupp AS Tallink Grupp (registration code 10238429, location and address at Sadama 5, 10111 Tallinn) held its Annual General Meeting of Shareholders on 7 May 2024 at 11 AM at the conference centre of Tallink SPA & Conference Hotel, at the address Sadama 11a, Tallinn. 86 shareholders were registered as attending at the Annual General Meeting of Shareholders, who owned 571,294,959 votes/shares (the amount of represented share capital 268,508,630.73 EUR), forming 76.83% of AS Tallink Grupp share capital. Resolutions ado...
Resolutions of the Annual General Meeting of Shareholders of AS Tallin...
Resolutions of the Annual General Meeting of Shareholders of AS Tallink Grupp AS Tallink Grupp (registration code 10238429, location and address at Sadama 5, 10111 Tallinn) held its Annual General Meeting of Shareholders on 7 May 2024 at 11 AM at the conference centre of Tallink SPA & Conference Hotel, at the address Sadama 11a, Tallinn. 86 shareholders were registered as attending at the Annual General Meeting of Shareholders, who owned 571,294,959 votes/shares (the amount of represented share capital 268,508,630.73 EUR), forming 76.83% of AS Tallink Grupp share capital. Resolu...
AS Tallink Grupp aktsionäride korralise üldkoosoleku otsused
AS Tallink Grupp aktsionäride korralise üldkoosoleku otsused AS-i Tallink Grupp (registrikood 10238429, asukoht ja aadress Sadama 5, 10111 Tallinn) aktsionäride korraline üldkoosolek toimus 7. mail 2024 algusega kell 11.00 Tallink SPA & Conference Hotelli konverentsikeskuses aadressil Sadama 11a, Tallinn. Korralisele üldkoosolekule registreerus 86 aktsionäri, kes omasid 571 294 959 aktsiat/häält (esindatud aktsiakapitali suurus oli 268 508 630.73 eurot), mis moodustab kokku 76,83% AS-i Tallink Grupp aktsiakapitalist. Koosoleku poolt vastu võetud otsused: 1. Kinnitada juhatu...
Descartes’ Annual Ecommerce Study Shows Online Buying Grows but 67% of...
Descartes’ Annual Ecommerce Study Shows Online Buying Grows but 67% of Consumers Face Delivery Problems ATLANTA and LONDON, May 07, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, released findings from , its third annual consumer sentiment study of ecommerce home delivery. The study shows that 39% of respondents made more online purchases in the period surveyed this year compared to last year, and that 57% made purchases in at least one new product category this year. While the study revea...
- Carol Dou Xiao Qin
- Sunny Chen
China Healthcare: From surviving to thriving.
Despite experiencing a prolonged funding winter, China’s biopharmaceutical market is still growing rapidly at a five-year CAGR of 6.9% in 2019-24, significantly outpacing the global market. Leading players have continuously enhanced their R&D capabilities, and their innovation efforts are bearing fruit. Innovation is driving growth and supporting the industry’s rosy outlook. The number of innovative drugs launched in China rocketed from 1 in 2017 to 34 in 2023. Our top picks are Innovent and Han...
Danske Bank AS: 1 director
A director at Danske Bank AS sold 168,499 shares at 197.490DKK and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Eduspec Holdings Berhad: 1 director
A director at Eduspec Holdings Berhad bought 22,400,000 shares at 0.147MYR and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Inari Amertron Bhd: 1 director
A director at Inari Amertron Bhd sold 2,050,000 shares at 0.000MYR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Gritee Inc: 1 director
A director at Gritee Inc bought 9,000 shares at 2,891.956KRW and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Robust Mix Sustained a Strong Start to the Year
Robust Mix Sustained a Strong Start to the Year Robust Mix Sustained a Strong Start to the Year Net revenues of Euro 1,585 million, up 10.9% versus prior year, with total shipments of 3,560 units $1flat versus Q1 2023Adjusted EBIT(1) of Euro 442 million, up 14.8% versus prior year, with adjusted EBIT(1) margin of 27.9%Adjusted net profit(1) of Euro 352 million and adjusted diluted EPS(1) at Euro 1.95Adjusted EBITDA(1) of Euro 605 million, up 12.7% versus prior year, with adjusted EBITDA(1) margin of 38.2%Industrial free cash flow(1) generation of Euro 321 million “The start of the year wa...
Cellectar Biosciences to Announce First Quarter Financial Results and ...
Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024 FLORHAM PARK, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the company will report its financial results for the three months ended March 31, 2024, on Tuesday, May 14, 2024. Management will also host a conference call with investors to discuss financial results and provi...
- ABGSC Credit Research
- Bendik Fougner Engebretsen
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.